YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Cliff Reid on Complete After BGI


May 15, 2013 | Complete Genomics CEO, Cliff Reid, talks about the future after BGI’s buyout. Reid believes that the price of genome tests must continue to come down further to make a difference in healthcare around the world. MendelsPod
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.